Previous close | 0.7040 |
Open | 0.7100 |
Bid | 0.0000 x 900 |
Ask | 0.0000 x 800 |
Day's range | 0.6932 - 0.7200 |
52-week range | 0.3650 - 1.6900 |
Volume | |
Avg. volume | 4,039,806 |
Market cap | 139.645M |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
Reata (RETA) reports a wider-than-expected loss in the second quarter of 2022, while revenues miss estimates. Stock falls after updates on pipeline programs.
Puma Biotech (PBYI) beats earnings and revenue estimates in second-quarter 2022. PBYI's stock surges at market close following the news.